Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 24, 2012 02:30 ET | Source: Active Biotech

Active Biotech och Ipsen presenterar på konferensen 27th European Association of Urology (EAU) för första gången långtidssäkerhetsdata från fas II-studien av tasquinimod (TASQ)

Lund och Paris den 24 februari, 2012 - Active Biotechs (NASDAQ OMX NORDIC: ACTI) och Ipsens (Euronext: IPN; ADR: IPSEY) projekt för behandling av kastratresistent prostatacancer, TASQ, kommer att...
February 24, 2012 02:30 ET | Source: Active Biotech

Active Biotech and Ipsen report for the first time Tasquinimod (TASQ) phase II long term safety data at the 27th European Association of Urology (EAU) Congress

Lund (Sweden) and Paris (France), February 24, 2012 - Active Biotech's (NASDAQ OMX NORDIC: ACTI) and Ipsen's (Euronext: IPN; ADR: IPSEY) castrate resistant prostate cancer project, TASQ will be...
February 16, 2012 02:30 ET | Source: Active Biotech

Active Biotech AB Bokslutsrapport januari - december 2011

· Laquinimod - en klinisk studie planeras innan registreringsansökan inlämnas i USA · TASQ - en prövarledd klinisk fas I-studie har...
February 16, 2012 02:30 ET | Source: Active Biotech

Year-end Report January - December 2011

· Laquinimod - a clinical trial is planned prior to filing an NDA in the US · TASQ - an investigator-sponsored Phase I clinical trial launched -...
January 23, 2012 02:30 ET | Source: Active Biotech

Active Biotechs prostatacancerprojekt TASQ i fas I klinisk studie som kombinationsterapi

Lund den 23 januari, 2012 - en prövarinitierad fas I klinisk studie under ledning av Dr. Andrew Armstrong vid Duke University Hospital, USA, har inletts för Active Biotechs (NASDAQ OMX Nordic: ACTI)...
January 23, 2012 02:30 ET | Source: Active Biotech

Active Biotech's Prostate Cancer Project TASQ in Phase I Combination Therapy Trial

Lund, Sweden, January 23, 2012 - a Phase I Investigator sponsored clinical trial, led by Principal Investigator Dr.Andrew Armstrong at Duke University Hospital, US, has been announced for Active...
January 04, 2012 02:30 ET | Source: Active Biotech

Active Biotech presenterar på JP Morgan 30th Annual Healthcare Conference

Lund den 4 januari 2012 - Active Biotech (NASDAQ OMX NORDIC: ACTI) kommer att presentera företaget på konferensen JP Morgan 30th Annual Healthcare Conference som hålls den 8-12 januari i San...
January 04, 2012 02:30 ET | Source: Active Biotech

Active Biotech to Present at the JP Morgan 30th Annual Healthcare Conference

Lund, Sweden, January 4, 2012 - Active Biotech (NASDAQ OMX NORDIC: ACTI) is scheduled to present at the JP Morgan 30th Annual Healthcare Conference held January 8-12, 2012 in San Francisco, US. During...
November 10, 2011 10:00 ET | Source: Active Biotech

Active Biotechs valberedning utsedd

Enligt beslut från årsstämman den 5 maj 2011, skall valberedningen för Active Biotech bestå av representanter för de, i slutet av september månad, tre största ägarna, samt styrelsens ordförande. ...
November 10, 2011 10:00 ET | Source: Active Biotech

Active Biotech's election committee appointed

In accordance with a decision made by the Annual General Meeting held on May 5, 2011, the Election Committee shall comprise the representatives for the three largest shareholders, as per end of...